“Under the Ayushman Bharat health insurance scheme, over 20 lakh tests and 7.25 lakh COVID-19 related treatments worth over Rs 2,800 crore were authorised from April 2020 to July 2021.The insurance scheme allows the beneficiaries to avail free testing and treatment across all empanelled — both public and private — hospitals,” an official said.
Category:
Pandemic
Latest
Over 3.86 crore people didn”t get 2nd dose of Covid vaccines within stipulated time: Govt
Indian states preparing for next COVID wave focus on children
As of March 2021, less than 1 pct of India’s coronavirus deaths were in the under 15 age group, according to the health ministry, and officials say the severity of the disease in this age group has been minimal so far.India provides vaccines to people above the age 18. Most vaccines administered in India are made by AstraZeneca Plc, while shots produced by local manufacturer Bharat Biotech are also being used.
U.S. FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump
Regeneron said on Saturday the clinical evidence from outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis and in patients who have not yet mounted their own immune response or who have high viral load
G20 leaders call for ‘affordable, equitable’ access to Covid-19 vaccine
“We need to avoid at all costs a scenario of a two-speed world where only the richer can protect themselves against the virus and restart normal lives,” French President Emmanuel Macron told the summit.
Indian-American doctor identifies possible COVID-19 treatment
Published online in the journal Cell, the research coming from the lab of Dr Thirumala-Devi Kanneganti, an Indian-born researcher working at St. Jude Children’s Research Hospital in Tennessee, identified the drugs after discovering that the hyper inflammatory immune response associated with COVID-19 leads to tissue damage and multi-organ failure in mice by triggering inflammatory cell death pathways
Swiss doctors urge COVID vulnerable to declare end-of-life wishes in advance
As health systems grapple with soaring infection rates, medical professionals working with limited resources and finite space in ICUs can at times face agonising dilemmas, and ethical questions around treating COVID-19 patients have spawned a government review in Britain and a court fight in Germany.
PM Modi holds meet to review India’s Covid vaccination strategy
Modi tweeted that the meeting discussed important issues related to progress of vaccine development, regulatory approvals and procurement. “Reviewed various issues like prioritisation of population groups, reaching out to HCWs (health care workers), cold-chain infrastructure augmentation, adding vaccinators and tech platform for vaccine roll-out,” he said.he prime minister directed that a time-bound plan be laid out for speedy regulatory clearances and timely procurement for early roll-out of the vaccination drive when a Covid-19 vaccine becomes available, an official statement later said.
Maha mulls suspension of trains, flights from Delhi amid Covid-19 surge
Various measures are being discussed in order to curb the virus spread in the state, and suspension of train and flight operations to and from Delhi is one of them,” principal secretary Sanjay Kumar told PTI. “However, no final decision has been taken so far,” he added.
Childhood vaccine may help prevent severe COVID-19
Pvt hospitals charged exorbitant fees for Covid-19 treatment:Par panel
“… Cost of health service delivery increased due to absence of specific guidelines for COVID treatment in private hospitals as a result of which patients were charged exorbitant fees,” the committee noted in the report.
Unilever to introduce mouthwash formulation in India, claims to reduce 99.9 pc corona after rinsing
Unilever Oral Care Research and Development Head Glyn Roberts said, “While we are clear that this is not a cure or proven way to prevent the transmission of coronavirus, our results are promising.”
This technology will be brought to India by Hindustan Unilever Ltd (HUL), Unilever”s arm, in Pepsodent Germicheck Mouth Rinse Liquid, which will be launched in India in December 2020, the company said.
G20 determined to use all tools to contain pandemic, save jobs, incomes
“We are determined to continue to use all available policy tools as long as required to safeguard people’s lives, jobs and incomes, support the global economic recovery and enhance the resilence of the financial system, while safeguarding against downside risks,” the statement said.